Leptospirosis Care Bundle Study

ConditionLeptospirosis

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorChulalongkorn University

About this trial

So in management of Leptospirosis patients There really is no another approach to treatment. The importance of the problem was acknowledged by the researchers. As a result, this study was performed in order to The Leptospirosis Care Bundle has been used, and has been proved that its use can reduce the risk of acute renal failure.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

age > 18 years

Suspicious Leptospirosis including body temperature > 38 celcius, Severe myalgia, and exposure to reservoir hospital of flood water.

Calf muscle tenderness

Conjunctival suffusion

Disqualifiers

other infectious disease

pregnancy

Trial design

Design model

Parallel

Treatments tested in this trial

Care Bundle
Procedure/Surgery
Treatment step by step we have 5 steps STEP 1: Leptospirosis suspected case STEP 2: Investigations STEP 3: Antibiotics within 1 hour after Hemocultures were taken STEP 4: Intravenous Fluid STEP 5: Stage-Base Management of AKI (KDIGO)

Treatment groups

300 Participants

are divided into 2 treatment groups

Group A: Care Bundle GroupExperimental treatment 1 intervention

Group B: Control GroupNo intervention 0 interventions

Trial outcomes

Primary outcomes

Number of Participants with Reduce AKI in 72 hours

To see if using care bundle for leptospirosis patients can improve reduce the incidence of acute renal failure in the first 72 hours of being admitted to hospital.It classified AKI into three categories (risk, injury, and failure) according to the status of serum creatinine (SCr) and urine output (UO) by AKIN/KDIGO

Time frame

72 hours

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Chulalongkorn University

Lead sponsor

Source ClinicalTrials.gov

Apply now